ID: ALA2336384

Max Phase: Preclinical

Molecular Formula: C12H18N8

Molecular Weight: 274.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)n1cnc2c(NC(=N)N)nc(NC3CC3)nc21

Standard InChI:  InChI=1S/C12H18N8/c1-6(2)20-5-15-8-9(17-11(13)14)18-12(19-10(8)20)16-7-3-4-7/h5-7H,3-4H2,1-2H3,(H5,13,14,16,17,18,19)

Standard InChI Key:  AOFAENYLJJMMGS-UHFFFAOYSA-N

Associated Targets(Human)

Aurora kinase A/B 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 2/cyclin E1 1877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 1/cyclin B1 1887 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 274.33Molecular Weight (Monoisotopic): 274.1654AlogP: 1.29#Rotatable Bonds: 4
Polar Surface Area: 117.53Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.02CX LogP: 0.89CX LogD: 0.18
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.49Np Likeness Score: -0.83

References

1. Dolečková I, Cesnek M, Dračinský M, Brynda J, Voller J, Janeba Z, Kryštof V..  (2013)  Synthesis and biological evaluation of guanidino analogues of roscovitine.,  62  [PMID:23399722] [10.1016/j.ejmech.2013.01.021]

Source